Amir Tooreseenin

Vice President, Head of Corporate Development

Amir Tooreseenin joined Boston Pharmaceuticals in 2020 as Senior Director of Corporate Development before assuming the assuming the role of Head of Corporate Development. Prior to joining Boston Pharmaceuticals, Amir was a Director of Business Development at Alnylam Pharmaceuticals where he successfully entered into a number of strategic collaborations and led the $2 billion strategic financing collaboration with Blackstone.

Before Alnylam, Amir was a senior investment professional at Malin plc, a publicly listed investment corporation that led venture rounds in Immunocore, Kymab, and Xenex Disinfection Services, and a Vice President in Evercore’s healthcare team where he helped execute on over $50 billion of announced M&A transactions. Prior to his career in healthcare, Amir was an engineer at Motorola.

Amir holds a BS in Mechanical Engineering from Purdue University and an MBA from Harvard Business School.